Novel associations of Claudin gene variants with kidney stone disease

Clicks: 17
ID: 321336
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #19 of 145 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 145 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background The tight junction family of claudin proteins regulates paracellular ion transport in the nephron and across epithelial and endothelial barriers throughout the body. Rare recessive variants in CLDN16 and CLDN19 cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), while common variants in CLDN2, CLDN10, and CLDN14 have been associated with kidney stones. Despite evidence that most CLDN proteins are expressed within the nephron, their genetic contribution to kidney stone susceptibility has not been systematically explored. Methods We analysed 415 237 UK Biobank participants (9 009 kidney stone cases and 406 228 controls) using exome sequencing and imputed genotype data spanning all 24 human CLDN genes. Single-variant association testing, gene burden analysis, and phenome-wide association studies were employed to identify novel associations. Results 43 novel coding variant associations were identified through exome sequencing, including two CLDN16 variants: p.Gly57Arg (rs747654138; OR = 42.23, P = 9.54 × 10−8) and p.Arg146His (rs772241737; OR = 60.45, P = 8.12 × 10−4). We replicated a known association with a CLDN19 variant, p.Arg200Gln (rs116804195; OR = 1.23, P = 2.57 × 10−4), which was also associated with decreased serum phosphate and increased alkaline phosphatase. We also identified 12 novel susceptibility loci within the imputed genotype dataset, including single nucleotide polymorphisms near CLDN2, CLDN10, CLDN11, CLDN18, and CLDN22–CLDN24 (all P < 0.00015), and confirmed a known CLDN14 association. Conclusions Beyond established FHHNC genes, multiple CLDN family members harbour variants potentially influencing kidney stone risk, possibly through altered paracellular transport and mineral homeostasis. These findings expand kidney stone genetic architecture and suggest that CLDN proteins merit further investigation in its pathogenesis.
Reference Key
openalex_W7168534527 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Iris Y Liu, Jenna Haverfield, Elby Mackenzie, Line Dufresne, Aimee K. Ryan, James C. Engert, Indra R. Gupta
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag237
URL
https://doi.org/10.1093/ckj/sfag237
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.